Fingolimod in Endovascular Treatment of Ischemic Stroke

Clinical trial NCT04629872 · UNKNOWN

Trial details

NCT number: NCT04629872
Sponsor: Ning Wang, MD., PhD.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stroke Inflammation

Start date: 2020-11-12
Primary completion: 2022-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.